A validated enantioselective HPLC assay of dexibuprofen in dexibuprofen tablet formulations

Biomedical Chromatography

Volumn 26, Issue 4, 2012, Pages 502-506

  Awad, Hanan ^a   Aboul Enein, Hassan Y ^b   Lashin, Sherif ^a  

^a Sigma Pharmaceutical Industries   (Egypt)

^b NATIONAL RESEARCH CENTRE   (Egypt)

Author keywords

Chiral analysis; Dexibuprofen; Enantioselective HPLC; Method validation; Stress degradation tests

Indexed keywords

DRUG DOSAGE; DRUG PRODUCTS; ENANTIOSELECTIVITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ISOMERS;

BULK DRUGS; CHIRAL ANALYSIS; DEGRADATION TEST; DEXIBUPROFEN; ENANTIOSELECTIVE HPLC; METHOD VALIDATIONS; PHARMACEUTICAL DOSAGE FORMS; STRESS DEGRADATION; STRESS DEGRADATION TEST; TABLET FORMULATIONS;

POTASSIUM COMPOUNDS;

DEXIBUPROFEN;

ACCURACY; ARTICLE; DRUG DEGRADATION; DRUG FORMULATION; DRUG HYDROLYSIS; DRUG STRUCTURE; ENANTIOSELECTIVITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; TABLET; VALIDATION STUDY;

EID: 84858004755     PISSN: 02693879     EISSN: 10990801     Source Type: Journal    
DOI: 10.1002/bmc.1694     Document Type: Article

References (11)

1. Adams SS, Bresloff P and Mason CG. Pharmacological differences between the optical isomers of ibuprofen: evidence for metabolic inversion of the (-)-isomer. Journal of Pharmacy and Pharmacology 1976; 28: 256-257.
2. Bonabello A, Galmozzi MR, Canaparo R, Isaia GC, Serpe L, Muntoni E and Zara GP. \Dexibuprofen (S(+)-isomer ibuprofen) reduces gastric damage and improves analgesic and antiinflammatory effects in rodents. Anesthesia and Analgesia 2003; 97: 402-408.
3. Busson M. Update on ibuprofen: review article. The Journal of International Medical Research 1986; 14(2): 53-62.
4. Caldwell J, Hutt AJ and Fournel-Cigleux S. The metabolic chiral inversion and dispositional enantioselectivity of the 2-arylpropionic acids and their biological consequences. Biochemical Pharmacology 1988; 37(1): 105-114.
5. Eller N, Kollenz CJ, Schiel H, Kikuta C and Mascher H. Pharmacokinetics of dexibuprofen administered as 200mg and 400mg film-coated tablets in healthy volunteers. International Journal of Clinical Pharmacology and Therapeutics 1998; 36(8): 414-417.
6. Grennan DM, Aarons L, Siddiqui M, Richards M, Thompson R and Higham C. Dose-response study with ibuprofen in rheumatoid arthritis: Clinical and pharmacokinetic findings. British Journal of Clinical Pharmacology 1983; 15: 311-316.
7. Hutt AJ and Caldwell J. The metabolic chiral inversion of 2-acrylpropionic acids - a novel route with pharmacological consequences. Journal of Pharmacy and Pharmacology 1983; 35(11): 693-704.
8. Laska EM, Sunshine A, Marrero I, Olson N, Siegel C and McCormick N. The correlation between blood levels of ibuprofen and clinical analgesic response. Clinical Pharmacology and Therapeutics 1986; 40: 1-7.
9. Naidong W and Lee JW. Development and validation of a liquid chromatographic method for the quantitation of ibuprofen enantiomers in human plasma. Journal of Pharmaceutical and Biomedical Analysis 1994; 12: 551-556.
10. Pettersson KJ and Olsson A. Liquid chromatographic determination of the enantiomers of ibuprofen in plasma using a chiral AGP Column. Journal of Chromatography. A 1991; 563(2): 414-418.
11. Teng XW, Wang SW and Davies NM. Stereospecific high-performance liquid chromatographic analysis of ibuprofen in rat serum. Journal of Chromatography B 2003; 796: 225-231.